Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome

• Status: Recruiting
• Trial end date: 2021-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

Polycystic ovary syndrome is the major cause of anovulatory infertility. Clomiphene citrate is the most commonly used oral agent for ovulation induction in this group, but there are some drawbacks with the use of it.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Letrozole

Criteria

Inclusion Criteria:

• History of at least one year of infertility either primary or secondary.

• Body mass index: 25-35

• Normal fallopian tubes

• Normal semen analysis of the husband

• Women who will accept to participate in the study

Exclusion Criteria:

• Body mass index above 35

• Contraindication to general anesthesia

• Previous laparoscopic drilling

• Presence of other causes of infertility

• Women who had received metformin, gonadotrophin, oral contraceptives or other hormonal drugs during the preceding 6 months

• Women who intended to start a diet program

• Women who will refuse to participate in the study.